Effects of riboflavin and amotosalen photoactivation systems for pathogen inactivation of fresh-frozen plasma on fibrin clot structure-Reference-Cited by-同舟云学术

Effects of riboflavin and amotosalen photoactivation systems for pathogen inactivation of fresh-frozen plasma on fibrin clot structure

Published:2015-09-10 Issue:1 Volume:56 Page:41-48
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Hubbard Thomas¹,Backholer Lucy²,Wiltshire Michael²,Cardigan Rebecca²,Ariëns Robert A.S.¹

Affiliation:

1. Theme Thrombosis, Division of Cardiovascular and Diabetes Research, Multidisciplinary Cardiovascular Research Centre and Leeds Institute for Genetics, Health and Therapeutics, Faculty of Medicine and Health, University of Leeds; Leeds

2. NHS Blood & Transplant; Cambridge UK

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13261/fullpdf

Reference25 articles.

1. . Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant;O'Shaughnessy;Br J Haematol,2004

2. Current prevalence and incidence of infectious disease markers and estimated window period risk in the American Red Cross blood donor population;Dodd;Transfusion,2002

3. Joint UKBTS Professional Advisory Committee Position Statement 2014 [Internet] http://www.transfusionguidelines.org.uk/document-library/position-statements/

4. A comparison of methods of pathogen inactivation of FFP;Rock;Vox Sang,2011

5. Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma;Wollowitz;Semin Hematol,2001

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inactivation of human plasma alters the structure and biomechanical properties of engineered tissues;Frontiers in Bioengineering and Biotechnology;2022-08-23

2. Visible 405 nm Violet-Blue Light Successfully Inactivates HIV-1 in Human Plasma;Pathogens;2022-07-08

3. Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia;JAMA Network Open;2021-11-29

4. Pathogen Reduction;Hematology/Oncology Clinics of North America;2019-10

5. Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026);Transfusion;2019-05-29